ReviR Therapeutics (溪砾科技)

Brisbane, California, United States

Drug Development AI drug discovery Therapeutics Biotech

ReviR Therapeutics (溪砾科技) is an innovative drug research and development company driven by artificial intelligence algorithms and genetic technologies. It focuses on RNA spatial structure calculation and has built the voyageRTMAI platform to develop small molecule drugs targeting RNA to address long-standing unmet clinical needs such as tumors and rare diseases.

✓Source: HealthTech Alpha by Galen Growth

Shareable draft

Check out ReviR Therapeutics (溪砾科技) on @MedStartr Today #DrugDevelopment #AllTherapeuticAreas #AIDrugDiscovery #Therapeutics #Biotech #MedMo #MedStartrVentures

https://www.medstartr.ai/s/ZC55v8iumxM

Get Involved in ReviR Therapeutics (溪砾科技)

🏢Is this your company? Claim This Profile

Join MedStartr to verify with your work email and edit this profile

Company Info

Founded: 2020
Website: revirtx.com/

Disease Areas

Drug Development All Therapeutic Areas

Technologies

AI AlgorithmsGenetic EngineeringDrug DevelopmentAI Drug Discovery

🌐Website

What do you think of ReviR Therapeutics (溪砾科技)?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Submit anonymously — my name won't be shown to the team or on this profile

Your scores and comments are shown with your review on this company's profile.